Agenus Inc (NAS:AGEN)
$ 14.56 0.99 (7.3%) Market Cap: 305.75 Mil Enterprise Value: 341.77 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Agenus Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 05:00PM GMT
Release Date Price: $40.8 (+8.51%)
Kelly Shi
Jefferies - Analyst

Thanks for joining Jefferies -- sorry -- Thank you for joining Jefferies New York Healthcare Conference. My name is Kelly Shi, one of the biotech analysts here. And in this session, we are very pleased to have Dr. Garo Armen, Chief Executive Officer, and Zack Armen, IR Director, from Agenus to join this fireside chat session. Welcome.

Zack Armen
Agenus Inc. - Head of IR

Thank you.

Garo Armen
Agenus Inc. - Chairman & CEO

Thank you very much, Kelly.

Kelly Shi
Jefferies - Analyst

Maybe we can start with a company introduction to the audience who are not super familiar with the story and what is your pipeline and what you're focused on at the moment.

Garo Armen
Agenus Inc. - Chairman & CEO

We'll be happy to do. Thank you very much all for attending this session as well and the future attendees via recording.

As some of you know, Agenus was born 29 years ago. And at the time our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot